小金粉
Search documents
加码中国市场 共享中国机遇 安利亮相2025进博会
Zhong Guo Xin Wen Wang· 2025-11-11 06:45
11月5日至10日,第八届进博会在上海举办,主题为"新时代,共享未来",设置食品及农产品、汽车、 技术装备、消费品、医疗器械及医药保健、服务贸易六大展区,展示461项新产品、新技术、新服务, 包括低空经济、人形机器人等未来产业,引入银发经济、冰雪经济、体育经济等新题材,导入数字消 费、健康消费等新平台,发展新型消费。 作为世界上首个以进口为主题的国家级博览会,进博会越发成为促进国际经贸合作、实现互利共赢的平 台,持续为中国和世界经济注入正能量。 进博会打造投资中国金字招牌,为全球企业带来新机遇。今年迎来投资中国30年的安利公司,再次亮相 进博会,针对公众对健康产品和服务多样化需求,从平台级健康解决方案、科创研发、安利扎根中国三 十年等维度,全面展现企业科研成果、创新产品,以及提升国民健康预期寿命、服务健康中国建设的努 力成果。 安利亮相2025进博会 安利(中国)董事长兼总裁余放表示,进博会的集聚效应,让全球企业一站式把握中国市场前沿脉搏,进 一步坚定在华持续投资信心;美国安利公司总部始终将中国作为全球最重要的战略级市场,作为大健康 行业领军企业和链主企业,安利仍将持续加大在华投入,不断延链、扩链、补链,为中 ...
安利赴约2025进博会:加码中国市场,领航健康未来
Cai Jing Wang· 2025-11-10 14:30
黄浦江畔,进博之约如期而至。 11月5日至10日,第八届进博会在上海举办,主题为"新时代,共享未来",设置食品及农产品、汽车、 技术装备、消费品、医疗器械及医药保健、服务贸易六大展区,展示461项新产品、新技术、新服务, 包括低空经济、人形机器人等未来产业,引入银发经济、冰雪经济、体育经济等新题材,导入数字消 费、健康消费等新平台,发展新型消费。 每年进博会,都成为安利推出创新产品的舞台。今年,安利围绕公众关切的健康诉求,针对国人日常饮 食新鲜水果蔬菜摄入较少、营养不均衡现状,首发首展一款补充人体日常所需维生素和矿物质的粉剂产 品,昵称"小金粉"。它是目前中国市场上第一款"蓝帽子"多维矿粉剂产品,富含19种维生素和矿物质, 方便和其他饮料餐食搭配,一次补足人体日常所需的维矿营养。 同时,安利重点展示以植物营养素为核心原料的产品组合及健康解决方案,如"抗衰系列产品",帮助人 们提升健康预期寿命,不仅活得长寿,还要活得更健康、更有质量: 细胞类抗衰产品:改善细胞衰老、线粒体受损,核心原料为铁皮石斛、野樱莓、槐花、石榴、余甘子提 取物; 行动力抗衰产品:提升骨密度,核心原料为淫羊藿、骨碎补、丹参提取物; 脑力抗衰产 ...
进博八载,“全勤生”的深耕与跨越:跨国药企的中国式成长|聚焦2025进博会
Hua Xia Shi Bao· 2025-11-08 02:57
Core Insights - The article highlights the significant growth and transformation of multinational pharmaceutical companies in China over the past eight years, particularly through their participation in the China International Import Expo (CIIE) [11] - Companies like Roche and Gilead are expanding their product offerings and localizing their operations, indicating a shift towards more comprehensive engagement in the Chinese market [3][5] Group 1: Roche's Expansion - Roche has evolved from showcasing a few oncology drugs at the first CIIE to presenting over 40 products and solutions this year, covering the entire industry chain from early research to localized production [3] - The company has launched nearly 15 products in China over the past eight years, with a new biopharmaceutical base in Shanghai aimed at producing large molecule antibody drugs locally [3][5] Group 2: Gilead's Innovations - Gilead is actively advancing local research and development, currently conducting 16 projects in China, including 10 in oncology, with 90% of these projects synchronized with global timelines [5] - The company introduced Lenacapavir, the first long-acting HIV prevention drug requiring only two doses per year, marking a significant milestone in HIV prevention [2][5] Group 3: AstraZeneca's Investments - AstraZeneca signed a $136 million investment agreement for its Qingdao base during the expo, emphasizing China's role as its second-largest market and a source of innovation [3] - The company has invested over $1.7 billion in projects driven by previous CIIE events, embedding its production supply chain deeply into the Chinese market [3] Group 4: Merck and Eli Lilly's Contributions - Merck showcased its first HIF-2α inhibitor for VHL syndrome patients and announced plans to introduce over 40 new products and indications in the next five years [5] - Eli Lilly has invested over 20 billion RMB in China, establishing a comprehensive industry chain from research to commercialization, and plans to continue expanding its local collaborations [5][10] Group 5: Amway's Local Innovations - Amway introduced a vitamin and mineral powder product, the first "blue hat" multivitamin in China, reflecting its commitment to local research and development [6][10] - The company has established a plant research center in Wuxi and is integrating AI and traditional Chinese medicine to enhance its product offerings [8][10] Group 6: The Broader Impact of CIIE - The CIIE has become a platform for global companies to redefine their roles in China, with many establishing local R&D centers and committing to long-term investments [10][11] - The event is seen as a bridge for innovation and trust between China and the world, showcasing the potential for Chinese-developed products to reach global markets [11][12]
安利携创新产品赴约2025进博会,在华投资持续加码
Bei Ke Cai Jing· 2025-11-07 06:33
11月5日至10日,第八届进博会在上海举办,主题为"新时代,共享未来"。作为世界上首个以进口为主题的国家级博览会,进博会越发成为促进国际经贸合 作、实现互利共赢的平台,持续为中国和世界经济注入正能量。 今年迎来投资中国30年的安利公司再次亮相进博会,针对公众对健康产品和服务多样化需求,从平台级健康解决方案、科创研发、扎根中国三十年等维度, 全面展现企业科研成果、创新产品,以及提升国民健康预期寿命、服务健康中国建设的努力成果。 安利亮相2025进博会 安利(中国)董事长兼总裁余放表示,进博会的集聚效应,让全球企业一站式把握中国市场前沿脉搏,进一步坚定在华持续投资信心;美国安利公司总部始 终将中国作为全球最重要的战略级市场,作为大健康行业领军企业和链主企业,安利仍将持续加大在华投入,不断延链、扩链、补链,贡献中国现代化产业 体系建设。 响应健康消费诉求 提升健康预期寿命 今年4月,商务部、国家卫健委等12部门印发《促进健康消费专项行动方案》,政策红利加速释放,健康消费站上风口,今年进博会医疗器械及医药保健展 区分外火爆。 每年进博会,都成为安利推出创新产品的舞台。今年,安利围绕公众关切的健康诉求,针对国人日常饮食 ...